Arrivo BioVentures LLC is a series b startup based in United States. 1 investor tracked.
Arrivo BioVentures LLC is a startup founded in 2025 based in the United States. Its most recent tracked round is Series B. Brouky records 1 investor associated with the company.
Arrivo BioVentures LLC is a biopharmaceutical company developing first-of-its-kind medicines that target the root cause of hard-to-treat diseases, with a focus on major depressive disorder and severe acute pancreatitis through novel drug candidates SP-624 and RABI-767.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.